Trial Profile
Effects of Valsartan on Metabolic Syndrome in Patients With Hypertension.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Valsartan (Primary) ; Antihypertensives
- Indications Hypertension; Metabolic syndrome
- Focus Therapeutic Use
- Acronyms KACT
- 28 Nov 2008 New trial record.